UA42745C2 - Спосіб виготовлення таблеток, які містять пароксетин, та таблетка, яка містить пароксетин - Google Patents

Спосіб виготовлення таблеток, які містять пароксетин, та таблетка, яка містить пароксетин

Info

Publication number
UA42745C2
UA42745C2 UA96062355A UA96062355A UA42745C2 UA 42745 C2 UA42745 C2 UA 42745C2 UA 96062355 A UA96062355 A UA 96062355A UA 96062355 A UA96062355 A UA 96062355A UA 42745 C2 UA42745 C2 UA 42745C2
Authority
UA
Ukraine
Prior art keywords
heading
prepare
normal
tablets
paroxetine tablets
Prior art date
Application number
UA96062355A
Other languages
English (en)
Russian (ru)
Inventor
Рам Дутта Патак
Девід Джордж Доті
Девид Джордж Доти
Original Assignee
Смітклайн Бічам Плс
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10746644&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA42745(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Смітклайн Бічам Плс, Смитклайн Бичам Плс filed Critical Смітклайн Бічам Плс
Publication of UA42745C2 publication Critical patent/UA42745C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Спосіб виготовлення пігулок, що містять пароксетин, включає виготовлення пігулок при відсутності води та без використання процесу мокрого гранулювання.
UA96062355A 1993-12-15 1994-12-14 Спосіб виготовлення таблеток, які містять пароксетин, та таблетка, яка містить пароксетин UA42745C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939325644A GB9325644D0 (en) 1993-12-15 1993-12-15 Novel formulation
PCT/EP1994/004164 WO1995016448A1 (en) 1993-12-15 1994-12-14 Paroxetine tablets and process to prepare them

Publications (1)

Publication Number Publication Date
UA42745C2 true UA42745C2 (uk) 2001-11-15

Family

ID=10746644

Family Applications (1)

Application Number Title Priority Date Filing Date
UA96062355A UA42745C2 (uk) 1993-12-15 1994-12-14 Спосіб виготовлення таблеток, які містять пароксетин, та таблетка, яка містить пароксетин

Country Status (36)

Country Link
US (1) US6113944A (uk)
EP (1) EP0734260B2 (uk)
JP (1) JP3037757B2 (uk)
KR (1) KR100367796B1 (uk)
CN (1) CN1071116C (uk)
AP (1) AP540A (uk)
AT (1) ATE180973T1 (uk)
AU (1) AU697982B2 (uk)
BG (1) BG62755B1 (uk)
BR (1) BR9408219A (uk)
CA (4) CA2274389C (uk)
CZ (1) CZ287891B6 (uk)
DE (1) DE69419033T2 (uk)
DK (1) DK0734260T4 (uk)
DZ (1) DZ1835A1 (uk)
ES (1) ES2132610T5 (uk)
FI (1) FI962445A0 (uk)
GB (1) GB9325644D0 (uk)
GR (1) GR3031047T3 (uk)
HK (1) HK1012285A1 (uk)
HU (1) HUT75880A (uk)
IL (1) IL111978A (uk)
MA (1) MA23395A1 (uk)
MY (1) MY112123A (uk)
NO (1) NO307366B1 (uk)
NZ (1) NZ277790A (uk)
OA (1) OA10297A (uk)
PL (1) PL314980A1 (uk)
RO (1) RO115413B1 (uk)
RU (1) RU2146141C1 (uk)
SA (1) SA94150373B1 (uk)
SI (1) SI0734260T2 (uk)
SK (1) SK282620B6 (uk)
UA (1) UA42745C2 (uk)
WO (1) WO1995016448A1 (uk)
ZA (1) ZA949900B (uk)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086053A1 (en) * 1993-12-15 2002-07-04 Smithkline Beecham Plc Formulations, tablets of paroxetine and process to prepare them
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
EP0994872B9 (en) 1997-06-10 2001-12-05 Synthon B.V. 4-phenylpiperidine compounds
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
WO2000078290A2 (en) * 1999-06-22 2000-12-28 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a salt of paroxetine
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
JP2004507504A (ja) * 2000-08-28 2004-03-11 シントン・ベスローテン・フェンノートシャップ パロキセチン組成物およびその製造方法
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
HUP0401946A2 (hu) 2001-07-31 2005-01-28 H. Lundbeck A/S Escitalopramot tartalmazó kristályos gyógyszerkészítmény
CA2464327A1 (en) * 2001-10-22 2003-05-30 Synthon B.V. N-formyl derivatives of paroxetine
EP1465601A4 (en) * 2001-12-28 2006-02-15 Teva Pharma STABLE PHARMACEUTICAL FORMULATION OF PAROXETINE ANHYDROUS HYDROCHLORIDE AND PREPARATION METHOD
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
WO2006009912A1 (en) * 2004-06-23 2006-01-26 Merck & Co., Inc. Estrogen receptor modulators
US20060063737A1 (en) * 2004-08-18 2006-03-23 Holmdahl Lisa K Liquid paroxetine compositions
US20060039975A1 (en) * 2004-08-20 2006-02-23 Zalman Vilkov Paroxetine formulations
US20060216345A1 (en) * 2005-03-24 2006-09-28 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition including paroxetine
CA2629514A1 (en) * 2005-11-14 2007-05-24 Auspex Pharmaceuticals, Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US20080033050A1 (en) * 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CN109771381B (zh) * 2017-11-13 2021-02-19 北京福元医药股份有限公司 一种帕罗西汀药物制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50116401A (uk) * 1974-03-04 1975-09-11
ZA813205B (en) † 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0223334B1 (en) * 1985-08-10 1991-07-10 Beecham Group Plc Process for the preparation of aryl-piperidine carbinols
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
EP0558679A1 (en) * 1990-11-24 1993-09-08 BEECHAM GROUP plc Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
CZ287891B6 (cs) 2001-03-14
AP9400704A0 (en) 1995-01-31
WO1995016448A1 (en) 1995-06-22
CA2274389C (en) 2004-09-14
BG62755B1 (bg) 2000-07-31
CZ176396A3 (en) 1996-09-11
GB9325644D0 (en) 1994-02-16
DK0734260T3 (da) 1999-11-15
SA94150373A (ar) 2005-12-03
CA2178637A1 (en) 1995-06-22
PL314980A1 (en) 1996-09-30
OA10297A (en) 1997-10-07
SK75696A3 (en) 1996-11-06
AU1314595A (en) 1995-07-03
CN1071116C (zh) 2001-09-19
ES2132610T3 (es) 1999-08-16
US6113944A (en) 2000-09-05
SK282620B6 (sk) 2002-10-08
IL111978A (en) 2000-07-16
BG100648A (bg) 1997-02-28
HU9601665D0 (en) 1996-08-28
RO115413B1 (ro) 2000-02-28
ES2132610T5 (es) 2008-12-16
CN1137236A (zh) 1996-12-04
AU697982B2 (en) 1998-10-22
KR100367796B1 (ko) 2003-07-22
SA94150373B1 (ar) 2006-05-27
CA2274387A1 (en) 1995-06-22
MA23395A1 (fr) 1995-07-01
SI0734260T2 (sl) 2008-12-31
NO962547D0 (no) 1996-06-14
HK1012285A1 (en) 1999-07-30
IL111978A0 (en) 1995-03-15
ZA949900B (en) 1995-10-10
NZ277790A (en) 1998-02-26
GR3031047T3 (en) 1999-12-31
MY112123A (en) 2001-04-30
JPH09506602A (ja) 1997-06-30
EP0734260B2 (en) 2008-07-09
DE69419033T2 (de) 1999-11-25
NO307366B1 (no) 2000-03-27
RU2146141C1 (ru) 2000-03-10
AP540A (en) 1996-09-20
HUT75880A (en) 1997-05-28
SI0734260T1 (en) 1999-08-31
ATE180973T1 (de) 1999-06-15
NO962547L (no) 1996-06-14
EP0734260A1 (en) 1996-10-02
DZ1835A1 (fr) 2002-02-17
CA2178637C (en) 1997-12-23
DE69419033D1 (de) 1999-07-15
DK0734260T4 (da) 2008-09-29
JP3037757B2 (ja) 2000-05-08
EP0734260B1 (en) 1999-06-09
CA2214575A1 (en) 1995-06-22
CA2274389A1 (en) 1995-06-22
CA2214575C (en) 1999-12-07
FI962445A (fi) 1996-06-12
BR9408219A (pt) 1997-08-26
FI962445A0 (fi) 1996-06-12

Similar Documents

Publication Publication Date Title
UA42745C2 (uk) Спосіб виготовлення таблеток, які містять пароксетин, та таблетка, яка містить пароксетин
HUT68689A (en) Alpha-heteroaryloxymethyl-ketones as interleukin-1-beta converting enzyme inhibitors, pharmaceutical compositions containing them, process for producing them and the compositions
MX9605272A (es) Proceso para preparar nicotinamida.
EP0228701A3 (en) 2-iodo-perfluoro-2-methylathanes, process for their production and their application
DE3662275D1 (en) Copper-chromium-titanium-silicon alloy, process for its production and its use
EP0436720A4 (en) HYDROLYZED MEMBRANE AND PROCESS FOR PRODUCING THE SAME.
ZA898101B (en) Bromonitro compound,process for the production thereof and use as blocide
SE9502941D0 (sv) Förfarande vid framställning av tabletter genom pressning samt tabletter framställda enligt förfarandet
DE3760617D1 (en) Aliphatic aldehydes, method for their production and their application as perfume agents
DK0415397T3 (da) Alkalisk pullulanase samt mikroorganisme og fremgangsmåde til fremstilling deraf
KR0156581B1 (en) 1,4-benzothiazine-2-acetic acid derivatives and process for production
ZA867940B (en) Delta2-1,2,4-triazolin-5-one derivatives,process for production thereof and uses thereof
EP0410554A3 (en) 14,17-alpha-ethano- and ethano-estratrienes, process for their production and their use in the production of pharmaceuticals
EP0654486A3 (en) Process for the production of copolymers.
GB9010973D0 (en) Cellulosic product,process for the production thereof and uses thereof
HUT71606A (en) Amino-ascorbic acid derivatives, halogen-ascorbic acid derivatives and process to prepare them
HU913711D0 (en) Hard capsule, and process for its production
DE3661072D1 (en) 16-oxa-bicycloû13.1.0¨-hexadec-7-ene, process for its production and its use as a perfume
WO1986002639A3 (fr) Application du diethyldithiocarbamate (dtc) a la preparation d'un medicament et son procede de preparation
HU913228D0 (en) Process for the production of 5-aroil-2,3-dihydro-1h-pyrrholyzine-1,1-dicarboxylates
AU1015088A (en) New compounds, processes for their production and uses thereof
EP0170517A3 (en) Process for the production of 1,2-amino alcohols
DE3476539D1 (en) 2,5-dihydro-5-arylimino-pyrroles, process for their production and their uses as herbicides
EP0601381A3 (en) Process for the production of 2,5 dibromopyridine.
HU911081D0 (en) Process for the fermentative production of d-izocitric acid